News - Pharmaphorum

Latest News

in News
Janssen and Arrowhead strike $3.7bn RNAi deal
October 5, 2018 Share
X
Janssen and Arrowhead strike $3.7bn RNAi deal
https://pharmaphorum.com/news/janssen-and-arrowhead-strike-3-7bn-rnai-deal/
in News
MS campaigner Trishna Bharadia scoops Woman of the Year award
September 20, 2018 Share
X
MS campaigner Trishna Bharadia scoops Woman of the Year award
https://pharmaphorum.com/news/ms-campaigner-trishna-bharadia-scoops-woman-of-the-year-award/

Lack of blood cancer awareness in China and Japan – Janssen report

Janssen has published a report revealing significant gaps in understanding of blood cancer in individuals in China and

Lack of blood cancer awareness in China and Japan – Janssen report

https://pharmaphorum.com/news/blood-cancer-awareness-china-japan-janssen/

Can pharma halt the world’s obesity crisis?

Lancet research reveals scale of problem

Can pharma halt the world’s obesity crisis?

https://pharmaphorum.com/views-and-analysis/can-pharma-halt-the-worlds-obesity-crisis/

NICE backs funding for Kyowa Kirin’s bone disorder drug

Children in England and Wales with a rare inherited disorder causing soft and weak bones can have access

NICE backs funding for Kyowa Kirin’s bone disorder drug

https://pharmaphorum.com/news/nice-backs-funding-for-kyowa-kirins-bone-disorder-drug/

See all

More news

FDA warns of genital gangrene risk with diabetes drug class

The US regulator released an official risk warning of a rare genital infection identified in 12 patients, including

FDA warns of genital gangrene risk with diabetes drug class

https://pharmaphorum.com/news/risk-sglt2-inhibitors-fda-warns/

England reveals plans allowing abortion pill to be taken at home

Women in England will be able to take an early abortion pill in the safety of their own

England reveals plans allowing abortion pill to be taken at home

https://pharmaphorum.com/news/england-reveals-plans-allowing-abortion-pill-to-be-taken-at-home/

Ada health app launches in Spanish and Portuguese

The most uninsured ethnic group in the US can now access health information via new Spanish and Portuguese

Ada health app launches in Spanish and Portuguese

https://pharmaphorum.com/news/ada-health-app-launches-spanish/

US start-up launches bilingual healthcare app

HoyHealth, an innovative health-tech start-up has launched HoyDoc, smartphone application that connects patients to medical providers through a

US start-up launches bilingual healthcare app

https://pharmaphorum.com/news/us-start-up-launches-bilingual-healthcare-app/

PM recognises MS advocate Trishna Bharadia’s volunteer work

Bharadia wins today’s ‘Points of Light’ award

PM recognises MS advocate Trishna Bharadia’s volunteer work

https://pharmaphorum.com/news/pm-recognises-ms-advocate-trishna-bharadias-volunteer-work/

NHS faces legal action over fertility treatment for gender transitioning patients

England’s NHS must offer transgender patients awaiting transitioning treatment access to fertility services, or face legal action according

NHS faces legal action over fertility treatment for gender transitioning patients

https://pharmaphorum.com/news/nhs-fertility-treatment-gender-transitioning-patients/

NHS saved £324 million by switching to biosimilars and generics

The UK’s national healthcare provider saved £324 million by switching its patients to “better value” biosimilar and generic

NHS saved £324 million by switching to biosimilars and generics

https://pharmaphorum.com/news/nhs-saved-millions-switching-biosimilars/

The first lipodystrophy treatment for European patients

Novelion Therapeutics’ Myalepta (metreleptin) developed for the ultra-rare condition lipodystrophy has been approved by the European Commission, giving

The first lipodystrophy treatment for European patients

https://pharmaphorum.com/news/the-first-lipodystrophy-treatment-for-european-patients/

HPV vaccination extended to thousands of boys in England

The UK government announced the extension of HPV vaccine programme to boys in a bid protect against several

HPV vaccination extended to thousands of boys in England

https://pharmaphorum.com/news/hpv-vaccination-extended-boys-england/

Chinese pharma contaminated with scandals

Another batch of vaccines have been found “substandard”, just days after the second-largest pharmaceutical company in China admitted

Chinese pharma contaminated with scandals

https://pharmaphorum.com/news/chinese-pharma-contaminated-scandals/

Pfizer backed off, but the price hike game continues

Donald Trump may have convinced the US pharma giant Pfizer to defer a price increase for dozens of

Pfizer backed off, but the price hike game continues

https://pharmaphorum.com/news/pfizer-backed-off-but-the-price-hike-game-continues/

Blood pressure drug recalled on cancer fears

Valsartan, a drug widely used to control blood pressure is being recalled in several countries around the world

Blood pressure drug recalled on cancer fears

https://pharmaphorum.com/news/valsartan-recalled-cancer-fears/

Pfizer defers drug price hike after Trump phone call

Pfizer has decided to defer the recent drug price increase after a long discussion with president Trump and

Pfizer defers drug price hike after Trump phone call

https://pharmaphorum.com/news/pfizer-defers-drug-price-hike-after-trump-phone-call/

Pharma takes leading role in NHS 70th anniversary celebrations

The pharmaceutical industry celebrated the 70th anniversary of the NHS by recognising the myriad contributions that the sector

Pharma takes leading role in NHS 70th anniversary celebrations

https://pharmaphorum.com/news/pharma-takes-leading-role-in-nhs-70th-anniversary-celebrations/

NHS app to end scramble for GP appointments

App is ‘world first’ according to health secretary

NHS app to end scramble for GP appointments

https://pharmaphorum.com/news/nhs-new-app-empowers-patients/

Search

Advanced Search

Trending

Latest News

More news